EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ethical Criteria for Improved Human Subject Protections in Phase I Healthy Volunteer Trials

Rebecca L Walker, Douglas MacKay, Margaret Waltz, Anne D Lyerly, Jill A Fisher

Ethics & Human Research · 2022-09 · 44 (5) · 2-21

DOI: 10.1002/eahr.500139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ethics & Human Research, 2022-09. Verfasst von Rebecca L Walker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Professor of social medicine and of philosophy at the University of North Carolina at Chapel Hill. Hauptthemen laut MEDLINE: Clinical Trials, Phase I as Topic, Ethics, Research. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phase I healthy volunteer trials test the safety and tolerability of investigational pharmaceuticals. In them, participants are exposed to study‐drug risks without the possibility of direct medical benefit and typically must spend days or weeks in a residential research facility. Monetary payments are used to incentivize enrollment and compensate participants for their time. Together, these features of phase I healthy volunteer trials create a research context that differs markedly from most other clinical research, including by enrolling disproportionate numbers of economically disadvantaged people of color as participants. Due to these unique trial features and participation patterns, traditional biomedical research oversight offers inadequate ethical and policy guidance for phase I healthy volunteer research. This article details five ethical criteria crafted to be responsive to the particularities of this type of research: translational science value, fair opportunity and burden sharing, fair compensation for service, experiential welfare, and enhanced voice and recourse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials, Phase I as TopicEthics, ResearchHealthy VolunteersHumansPolicyVulnerable Populations

Stichwörter der Autor:innen

Belmont Reportcompensation for researchhealthy volunteershuman subjects researchphase I trials

Autor:innen und Institutionen

  • Professor of social medicine and of philosophy at the University of North Carolina at Chapel Hill.
  • Associate professor of public policy at the University of North Carolina at Chapel Hill.
  • Research associate in the Department of Social Medicine at the University of North Carolina at Chapel Hill.
  • Professor of social medicine and on the core faculty in the Center for Bioethics at the University of North Carolina at Chapel Hill.

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences of the National Institutes of Health

Zitieren

APA

Walker, R. L., MacKay, D., Waltz, M., Lyerly, A. D., & Fisher, J. A. (2022). Ethical Criteria for Improved Human Subject Protections in Phase I Healthy Volunteer Trials. Ethics & Human Research, 44(5), 2-21. https://doi.org/10.1002/eahr.500139

Vancouver

Walker RL, MacKay D, Waltz M, Lyerly AD, Fisher JA. Ethical Criteria for Improved Human Subject Protections in Phase I Healthy Volunteer Trials. Ethics & Human Research. 2022;44(5):2-21. doi:10.1002/eahr.500139

BibTeX
@article{Walker2022,
  author = {Walker, Rebecca L and MacKay, Douglas and Waltz, Margaret and Lyerly, Anne D and Fisher, Jill A},
  title = {Ethical Criteria for Improved Human Subject Protections in Phase I Healthy Volunteer Trials},
  journal = {Ethics & Human Research},
  year = {2022},
  volume = {44},
  number = {5},
  pages = {2--21},
  doi = {10.1002/eahr.500139}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche